Merck KGaA nears $3.5bn deal for SpringWorks
Merck KGaA is edging closer to the SpringWorks deal, which was first rumoured in February, confirming late-stage negotiations at an estimated price of $47 per share – potentially valuing the deal at around $3.5bn.
The company confirmed in a 24 April statement that while no final, legally binding agreement has been established, the 'parties are in discussion on the basis of a price of around $47 per share.'
The news follows months of speculation. Market chatter around a potential acquisition began on 10 February 2025, when Reuters reported that Merck KGaA was exploring a deal. That same day, the German pharma firm acknowledged the discussions, but cautioned that there was no guarantee of a transaction. Following the report, SpringWorks shares jumped 34%, pushing the company's market capitalisation over $4bn. Merck KGaA's CEO Belén Garijobut declined to provide updates on the deal during the company's full-year earnings press call in March, keeping investors in suspense.
Shares in SpringWorks were up by almost 9% when the markets opened on 25 April, after the latest development.
A successful acquisition would bolster Merck KGaA's oncology portfolio with SpringWork's pipeline of targeted therapies. These include Ogsiveo (nirogacestat), which is approved for treating desmoid tumours, as well as the MEK inhibitor Gomekli (mirdametinib), which was approved in February 2025 for treating neurofibromatosis type 1 (NF1), a rare genetic disorder.
According to projections from GlobalData's Pharma Intelligence Center, Gomekli is projected to generate up to $564m in global sales by 2030, while Ogsiveo sales are expected to reach $1.2bn by the same year.
GlobalData is the parent company of Pharmaceutical Technology.
Merck KGaA already has a strong oncology pipeline. Its top-selling product in 2024 was Erbitux (cetuximab), which generated €1.16bn ($1.25bn) in revenue. The drug is a monoclonal antibody used to treat certain head and neck cancers, and colorectal cancer.
However, not all programs have been as successful. In June 2024, Merck KGaA terminated the Phase III TrilynX clinical trial of xevinapant after the drug failed to significantly improve survival in patients with locally advanced head and neck cancer.
Additionally, Merck KGaA has faced setbacks in its neurology pipeline, including the discontinuation of BTK inhibitor evobrutinib in March 2024. The decision followed two Phase II trials in relapsing multiple sclerosis, where the drug did not achieve a statistically significant reduction in annual relapse rates compared to Sanofi's Aubagio (teriflunomide). The programme had already come under scrutiny in April 2023, when the US Food and Drug Administration (FDA) placed a partial clinical hold on a Phase III study after cases of liver injury were reported.
Merck KGaA has continued to prioritise the expansion of its oncology portfolio. Earlier in April 2025, the company signed a $1.4bn multi-year collaboration with Caris Life Sciences to access novel antibody-drug conjugate (ADC) targets. Under the agreement, Caris will identify tumour-associated targets, which Merck KGaA will take into preclinical and clinical development. Merck KGaA also has an internal ADC programme, with its lead candidate M9140 currently in Phase I trials for colorectal cancer.
"Merck KGaA nears $3.5bn deal for SpringWorks" was originally created and published by Pharmaceutical Technology, a GlobalData owned brand.
The information on this site has been included in good faith for general informational purposes only. It is not intended to amount to advice on which you should rely, and we give no representation, warranty or guarantee, whether express or implied as to its accuracy or completeness. You must obtain professional or specialist advice before taking, or refraining from, any action on the basis of the content on our site.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
New York Post
an hour ago
- New York Post
German town offers free 2-week stay to lure people to relocate there
A German town trying to beef up its population is luring in new residents by offering them a two-week trial accommodation — on the house. Eisenhüttenstadt, around 60 miles from Berlin, was built in 1950. dpa/picture alliance via Getty Images Eisenhüttenstadt, around 60 miles from Berlin, is accepting applications for the program — which will run from Sept. 6 to 20 — until the beginning of July. Advertisement 'The project is aimed at anyone interested in moving to Eisenhüttenstadt—such as commuters, those interested in returning to the town, skilled workers, or self-employed individuals seeking a change of scenery,' the local council said in a statement, according to CNN Travel. The initiative in the city, which now has a population of around 24,000, is part of an 'innovative immigration project' named 'Make Plans Now,' the council continued. Local businesses will offer internships and job shadowing. dpa/picture alliance via Getty Images Advertisement Those enrolled in the program will also participate in activities designed just for them, including a tour of Eisenhüttenstadt, home to historical buildings from the Soviet era. One man was so captivated by its architecture that he had already moved there. 'We were traveling to Ratzdorf with friends and drove through Karl-Marx-Straße. And I saw these houses, this architecture that completely blew me away, and I said to my wife, 'I'm going to move here,'' he wrote on the town hall's Instagram account. Eisenhüttenstadt, which means Steel Mill Town, was built around a steel mill. Guests will get the chance to explore its factories as well. Advertisement The town also houses the largest integrated steelworks facility in eastern Germany, which employs 2,500 people and acts as a metals processing hub. Local businesses will also offer internships, job shadowing and conduct interviews with tourists, who can move there and join their labor force. Founded in 1950, Eisenhüttenstadt was the first town built from scratch under then East Germany's socialist government. At its peak, it boasted a population of 50,000. Advertisement It was originally named Stalinstadt, or Stalin Town, after the late Soviet leader, Joseph Stalin, but was renamed after the fall of the Berlin Wall in 1989 and the German reunification.
American Military News
4 hours ago
- American Military News
‘Have a nice day, DJT!': Trump's breakup with Musk devolves into a war of insults
President Donald Trump's friendship and political alliance with Elon Musk, the world's richest man, who fueled Trump's campaign with record amounts of cash before working at the White House by his side until last week, appears to be over, with both men leveling searing criticism against one another in a sharp public row. Musk had been criticizing the Trump administration over its signature legislation, the 'One Big Beautiful Bill Act,' for its projected impact on the national debt throughout last week. But his calls to 'kill the bill' on Wednesday prompted Trump, speaking to media from the Oval Office, to respond in kind. 'Elon and I had a great relationship, I don't know if we will anymore,' Trump said Thursday. 'And he hasn't said bad things about me personally, but I'm sure that'll be next. But I'm very disappointed in Elon.' Musk, responding on his social media platform, X, took credit for Trump's election victory. The billionaire entrepreneur, whose companies also include SpaceX and Tesla, contributed over $280 million to Trump and other Republicans during the 2024 presidential campaign. 'Without me, Trump would have lost the election, Dems would control the House and the Republicans would be 51-49 in the Senate,' Musk wrote. 'Such ingratitude.' Matters only deteriorated as the day progressed. After meeting with the German chancellor, Trump wrote on social media that the 'easiest way' to save billions in federal spending would be to 'terminate Elon's government subsidies and contracts.' 'Make my day,' Musk shot back, before claiming in a subsequent post that Trump had withheld the full release of FBI files on Jeffrey Epstein, the late child sex offender, because they would implicate the president himself. 'Time to drop the really big bomb: Trump is in the Epstein files,' Musk wrote. 'That is the real reason they have not been made public. Have a nice day, DJT!' The exchange broke open a feud that had been simmering for weeks out of public view. In private, Musk had relayed concerns over the bill to the president, while expressing disagreement with several other policies, including the establishment of an artificial intelligence campus in the Middle East and Trump's announcement of global tariffs. 'I agree with much of what the administration does, but we have differences of opinion,' Musk said in a more muted tone last week, speaking in an interview with CBS. 'You know, there are things that I don't entirely agree with. But it's difficult for me to bring that up in an interview because then it creates a bone of contention,' he added. 'So then, I'm a little stuck in a bind, where I'm like, well, I don't wanna, you know, speak up against the administration, but I also don't wanna take responsibility for everything this administration's doing.' In the Oval Office, Trump said he believed that Musk had turned on him after he rejected Musk's recommendation for the head of NASA, a position that could benefit SpaceX, Musk's spaceship company. He also said that Musk opposed provisions of Trump's megabill that would phase out tax credits for electric vehicles. 'Elon knew the inner workings of this bill better than almost anybody sitting here. Better than you people. He knew everything about it — he had no problem with it. All of a sudden he had a problem, and he only developed the problem when he found out that we're going to have to cut the EV mandate, because that's billions and billions of dollars,' Trump said. 'People leave my administration and they love us, and at some point, they miss it so badly, and some of them embrace it, and some of them actually become hostile,' Trump added. 'I don't know what it is.' But Musk denied he had been shown the bill, responding on X that he wouldn't mind if the EV provisions remain in the text so long as others, which he said would balloon annual deficits, are cut. 'This bill was never shown to me even once and was passed in the dead of night so fast that almost no one in Congress could even read it!' Musk wrote. 'Keep the EV/solar incentive cuts in the bill, even though no oil & gas subsidies are touched (very unfair!!), but ditch the MOUNTAIN of DISGUSTING PORK in the bill.' The nonpartisan Congressional Budget Office released an assessment on Wednesday estimating that the 'big, beautiful bill,' which has passed the House and is under consideration in the Senate, would add $2.4 trillion to the national debt over the next decade, and result in 10.9 million Americans losing health insurance coverage over the same period. At the beginning of the administration, Trump put Musk in charge of the Department of Government Efficiency, or DOGE, a White House program that intended on cutting federal spending and reducing the deficit. Musk's tenure in the role, designated as a special government employee, ended last week. On X, Musk posted a collection of past remarks from Trump warning against growing deficits and congressional actions increasing the debt ceiling, adding, 'where is this guy today?' 'Either you get a big and ugly bill or a slim and beautiful bill,' Musk added. 'Slim and beautiful is the way.' ___ © 2025 Los Angeles Times. Distributed by Tribune Content Agency, LLC.
Yahoo
5 hours ago
- Yahoo
Sunderland Reject Dortmund's Bid for Jobe Bellingham Amid Ongoing Talks
Sunderland Standing Firm as Dortmund Pursue Jobe Bellingham Quiet Confidence Behind Stubborn Negotiations AFC Sunderland's resolve is being tested, and so far, they're not blinking. According to Sky Sports Germany, Borussia Dortmund's pursuit of Jobe Bellingham is active but far from complete. The Bundesliga giants' latest offer, reportedly under €25 million, has been firmly rejected by the newly promoted Premier League side. The report also states that 'Sunderland is proving to be a tenacious negotiator.' Advertisement Negotiations are ongoing, with BVB representatives Sebastian Kehl and Lars Ricken engaged in discussions with Sunderland's Kristjaan Speakman and Kyril Louis-Dreyfus. The German side is expected to return with an improved offer. Despite the standoff, there is a sense of quiet optimism. 'All parties remain optimistic that the deal will close soon,' Sky reports. The idea of a €30 million package, including add-ons, may yet be the key to unlocking the deal. Photo IMAGO Why Dortmund Are Keen This isn't just about sentimentality. While the Bellingham surname carries immense weight in Dortmund, after Jude Bellingham's outstanding spell before joining Real Madrid, this move is centred on Jobe's potential, not his brother's legacy. Advertisement Now 18, the younger Bellingham has carved his own path. In his first full season at Sunderland, he has shown maturity beyond his years and a versatility that appeals to clubs with high ambitions. He can operate as a central midfielder, No.10, or even in wider areas. Dortmund, famed for developing young talent, see him as another long-term project. Reports from Sky Sports confirm that 'Bellingham has agreed a five-year contract with Dortmund.' Timelines and Club World Cup Planning The deal's timing is crucial. Bellingham has been selected for England's U21 European Championship squad and is due to travel to Slovakia. However, 'If there is a breakthrough in the negotiations – this has been agreed – Bellingham would travel to Dortmund and then also to the Club World Cup in the USA.' Advertisement It's a clear sign of intent from Dortmund, not just for the future but also for the present. They want Bellingham involved immediately, potentially using the Club World Cup as a platform for integration. Photo: IMAGO Sunderland's Position of Strength Sunderland's stance is more than just financial prudence, it's reflective of a club with a long-term vision. Having returned to the Premier League, they are no longer content to be a stepping stone. Jobe Bellingham may ultimately leave, but it will be on Sunderland's terms, at the right price, and with the right future guarantees. This negotiation is not only about one player, it is about perception, leverage, and ambition. Our View – EPL Index Analysis For Sunderland, this negotiation feels like a moment of arrival. For too long, the club has seen talent depart on cut-price deals. Now, they're holding firm. While losing a player of Bellingham's promise would sting, the insistence on a deal that reflects his market value signals real intent. There's belief that this club can both develop stars and drive a hard bargain. Advertisement On the other hand, for Borussia Dortmund, the deal makes perfect sense. It mirrors their usual model, spotting emerging talent, offering a step up, and integrating with patience and purpose. Having Jude's legacy in their locker only adds sentimental weight. But this isn't just a name play, Jobe fits Dortmund's blueprint: young, tactically adaptable, and with significant resale potential. If €30 million is indeed the magic number, it represents a calculated gamble for Dortmund and a statement of growth from Sunderland. One way or another, this is a deal that speaks volumes about both clubs.
